Dr. Marshall Morrison , MD
Internal Medicine • Azle, TX
141 Industrial Ave
Azle, TX 760202901
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Dr. Marshall Morrison is listed in NPPES under Internal Medicine.
-
NPI assigned on January 25, 2006; this date does not establish years in practice.
-
Published CMS data list 677 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- 99214 — Established patient outpatient office visit: 249 service units.
- G2211 — Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's: 221 service units.
- 99215 — Established patient outpatient office visit: 61 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 9 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 8,448 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Levothyroxine Sodium — 372 prescription fills, including refills.
- Atorvastatin Calcium — 269 prescription fills, including refills.
- Pantoprazole Sodium — 269 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 149 records in the table · Guide: How to read Medicare Part D prescriber data
-
Close to the middle for Medicare Part B services among clinicians listed under Internal Medicine in Texas (2024, 5,423 clinicians with data). Median for this group: 645. Middle half: 277 to 1,322.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 2,011 in 2020 to 677 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
141 Industrial Ave
Azle, TX 760202901
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
What Public CMS Data Show
Internal Medicine: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
211 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $46,330 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $23,075 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
17,147 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$499,222 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2024
All general payments: $566.25 across 28 records.
By nature of payment
- Food and Beverage: $566.25 across 28 records.
Reporting-company totals (3 largest of 10)
- ABBVIE INC.: $191.37 across 9 records.
- GlaxoSmithKline, LLC.: $133.54 across 6 records.
- Boehringer Ingelheim Pharmaceuticals, Inc.: $58.38 across 3 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2024 (published June 30, 2026).
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Morrison has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Morrison as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Azle and Texas
Billing and prescribing volume is not a quality rating.
Medicare Part B services
Close to the middle for clinicians listed under Internal Medicine in Texas (2024, 5,423 clinicians with data). Median for this group: 645. Middle half: 277 to 1,322.
Too few clinicians listed under Internal Medicine in Azle have Medicare Part B data for 2024 to compare.
Medicare-allowed amount
A lower Medicare-allowed amount than 60% of clinicians listed under Internal Medicine in Texas (2024, 5,423 clinicians with data). Median for this group: $61,221. Middle half: $27,420 to $115,826.
Too few clinicians listed under Internal Medicine in Azle have Medicare Part B data for 2024 to compare.
Paid by Medicare
A lower Medicare payment amount than 70% of clinicians listed under Internal Medicine in Texas (2024, 5,423 clinicians with data). Median for this group: $47,501. Middle half: $20,446 to $90,051.
Too few clinicians listed under Internal Medicine in Azle have Medicare Part B data for 2024 to compare.
Medicare Part D prescriptions
More Part D prescriptions than 85% of clinicians listed under Internal Medicine in Texas (2024, 5,674 clinicians with data). Median for this group: 828. Middle half: 121 to 4,824.
Too few clinicians listed under Internal Medicine in Azle have Medicare Part D data for 2024 to compare.
Part D drug cost
A higher Part D drug cost than 75% of clinicians listed under Internal Medicine in Texas (2024, 5,674 clinicians with data). Median for this group: $64,859. Middle half: $4,211 to $436,775.
Too few clinicians listed under Internal Medicine in Azle have Medicare Part D data for 2024 to compare.
12 active clinicians are listed under Internal Medicine with a practice address in Azle, TX (9,191 in Texas).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Azle
25% of these 12 clinicians have the CMS telehealth indicator.
58.3% of these 12 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services decreased 66% from 2,011 in 2020 to 677 in 2024.
- 2020: 2,011
- 2021: 1,798
- 2022: 1,767
- 2023: 1,517
- 2024: 677
-
Medicare-allowed amount
Medicare-allowed amount decreased 67% from $140,197 in 2020 to $46,330 in 2024.
- 2020: $140,197
- 2021: $134,183
- 2022: $120,268
- 2023: $103,399
- 2024: $46,330
-
Paid by Medicare
Paid by Medicare decreased 76% from $97,779 in 2020 to $23,075 in 2024.
- 2020: $97,779
- 2021: $87,543
- 2022: $82,194
- 2023: $68,502
- 2024: $23,075
-
Medicare Part D prescriptions
Medicare Part D prescriptions decreased 54% from 18,559 in 2020 to 8,448 in 2024.
- 2020: 18,559
- 2021: 17,235
- 2022: 16,540
- 2023: 17,034
- 2024: 8,448
-
30-day fills
30-day fills decreased 52% from 36,006 in 2020 to 17,147 in 2024.
- 2020: 36,006
- 2021: 34,398
- 2022: 33,775
- 2023: 33,961
- 2024: 17,147
-
Part D drug cost
Part D drug cost decreased 54% from $1,089,038 in 2020 to $499,222 in 2024.
- 2020: $1,089,038
- 2021: $1,068,198
- 2022: $1,259,853
- 2023: $1,299,146
- 2024: $499,222
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $920.27 in 2020 to $566.25 in 2024.
- 2020: $920.27
- 2021: $1,289.14
- 2022: $1,138.75
- 2023: $1,190.35
- 2024: $566.25
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2024), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2024 (payments made January 1 – December 31, 2024): 28 records totaling $566.25.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
SHINGRIX | General | $98.80 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
QULIPTA | General | $33.75 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
QULIPTA | General | $33.75 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
UBRELVY | General | $29.86 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
VRAYLAR | General | $28.32 |
| Phathom Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
VOQUEZNA | General | $25.40 |
| Corium, LLC |
Food and Beverage
In-kind items and services
|
Azstarys | General | $24.06 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
VRAYLAR | General | $22.07 |
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Veozah | General | $20.26 |
| Boehringer Ingelheim Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
JARDIANCE | General | $20.20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
JARDIANCE | General | $20.06 |
| Dexcom, Inc. |
Food and Beverage
In-kind items and services
|
Dexcom G6 Transmitter | General | $19.50 |
| Boehringer Ingelheim Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
JARDIANCE | General | $18.12 |
| Eli Lilly and Company |
Food and Beverage
In-kind items and services
|
MOUNJARO | General | $17.91 |
| Eli Lilly and Company |
Food and Beverage
In-kind items and services
|
JARDIANCE | General | $15.93 |
| Eli Lilly and Company |
Food and Beverage
In-kind items and services
|
MOUNJARO | General | $15.65 |
| IDORSIA PHARMACEUTICALS US INC |
Food and Beverage
In-kind items and services
|
QUVIVIQ | General | $15.62 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
UBRELVY | General | $14.88 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
ELIQUIS | General | $14.60 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
QULIPTA | General | $14.59 |
| IDORSIA PHARMACEUTICALS US INC |
Food and Beverage
In-kind items and services
|
QUVIVIQ | General | $14.03 |
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
TRELEGY ELLIPTA | General | $10.47 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
VRAYLAR | General | $9.79 |
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
SHINGRIX | General | $9.05 |
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
TRELEGY ELLIPTA | General | $6.15 |
(top 25 shown)
Source: CMS Open Payments, program year 2024, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
249 | 173 | $323.00 | $122.00 |
|
G2211
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
|
221 | 169 | $18.00 | $15.55 |
|
99215
Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
|
61 | 51 | $435.00 | $171.77 |
|
80305
Testing for presence of drug, read by direct observation
|
37 | 37 | $38.00 | $12.35 |
|
96372
Injection of drug or substance under skin or into muscle
|
35 | 30 | $73.00 | $13.57 |
|
J1040
Injection, methylprednisolone acetate, 80 mg
|
28 | 25 | $19.36 | $9.72 |
|
G0179
Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a
|
16 | 11 | $128.00 | $39.57 |
|
82947
Blood glucose (sugar) level
|
15 | 15 | $17.00 | $3.85 |
|
83036
Hemoglobin a1c level
|
15 | 15 | $43.00 | $9.52 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 372 | 29,114 | $4,327.99 | 146 |
| Atorvastatin Calcium | Atorvastatin Calcium | 269 | 19,958 | $2,327.59 | 103 |
| Pantoprazole Sodium | Pantoprazole Sodium | 269 | 18,619 | $3,631.98 | 98 |
| Amlodipine Besylate | Amlodipine Besylate | 250 | 18,274 | $1,662.20 | 100 |
| Gabapentin | Gabapentin | 226 | 12,056 | $5,273.99 | 73 |
| Metoprolol Succinate | Metoprolol Succinate | 222 | 16,860 | $3,285.38 | 86 |
| Losartan Potassium | Losartan Potassium | 199 | 15,562 | $2,368.95 | 81 |
| Lisinopril | Lisinopril | 191 | 15,692 | $1,672.72 | 82 |
| Memantine Hcl | Memantine Hcl | 186 | 9,796 | $3,556.29 | 57 |
| Potassium Chloride | Potassium Chloride | 184 | 12,342 | $6,150.53 | 69 |
| Quetiapine Fumarate | Quetiapine Fumarate | 172 | 8,251 | $2,708.90 | 65 |
| Omeprazole | Omeprazole | 169 | 11,484 | $2,804.70 | 60 |
| Alprazolam | Alprazolam | 134 | 3,893 | $634.83 | 44 |
| Furosemide | Furosemide | 134 | 8,299 | $1,066.69 | 62 |
| Tamsulosin Hcl | Tamsulosin Hcl | 133 | 9,505 | $1,943.75 | 56 |
| Montelukast Sodium | Montelukast Sodium | 129 | 9,036 | $1,423.45 | 46 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 126 | 7,726 | $1,755.48 | 40 |
| Eliquis | Apixaban | 126 | 5,920 | $106,320.32 | 35 |
| Prednisone | Prednisone | 125 | 2,133 | $471.84 | 77 |
| Clopidogrel | Clopidogrel Bisulfate | 124 | 8,016 | $1,511.48 | 42 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 120 | 9,900 | $2,129.73 | 44 |
| Carvedilol | Carvedilol | 105 | 7,365 | $756.64 | 41 |
| Metformin Hcl | Metformin Hcl | 103 | 6,750 | $832.78 | 42 |
| Estradiol | Estradiol | 100 | 6,722 | $1,866.52 | 41 |
| Trazodone Hcl | Trazodone Hcl | 100 | 6,274 | $1,795.91 | 33 |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2022-02-17NUCC Taxonomy Code: 207R00000X
A physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - INTERNAL MEDICINE
I20100518000144
TX
9032247713
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Nurse Practitioner - Family
Family Nurse Practitioner (Certified)
Nurse Practitioner - Family
Family Nurse Practitioner (Certified)
Physician Assistant
Physician Assistant (Certified)
Nurse Practitioner - Family
Family Nurse Practitioner
Nurse Practitioner - Family
Registered Nurse, Master of Science in Nursing, Family Nurse Practitioner (Certified)
Nurse Practitioner - Family
Nurse Practitioner
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 141 INDUSTRIAL AVE, AZLE, TX 760202901 (Tel: 8172703132)
Registered at 141 INDUSTRIAL AVE, AZLE, TX 760202901 (Tel: 8172703132)
Registered at 137 INDUSTRIAL AVE STE A, AZLE, TX 760202991 (Tel: 8172700337)
Registered at 137 INDUSTRIAL AVE STE A, AZLE, TX 760202991
Recorded as MARSHALL MORRISON, MD
NPI status registered as active in NPPES database
Registered at 112 DENVER TRL, AZLE, TX 760203614 (Tel: 8172703132)
Registered at 4504 BOAT CLUB RD, SUITE 800, FORT WORTH, TX 761357003 (Tel: 8172703132)
Recorded as MARSHALL MORRISON, M.D.
Internal Medicine (license number reported to NPPES: TX G5405)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Internal Medicine Providers in Azle
- Dr. Kenneth Hamilton, MD
- Dr. Kelvin Robison, MD
- Dr. Kavitha Mamindla, MD
- Dr. Kavita Shah, MD
- Dr. Michael Mcfarland, DO
- Dr. Kifle Admassu, MD
Mailing Address
141 Industrial Ave
Azle, TX 760202901
Phone: 8172703132